Company profile for APR Applied Pharma Research

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

APR Applied Pharma Research s.a. (APR) is a Swiss Pharma company dedicated to providing patients suffering from rare diseases with innovative treatments that make a real difference in their life. Our focus as a Swiss global health care company is the identification, research, development, manufacturing, registration and commercialization of innovative, proprietary, science driven products designed to address patients' needs in...
APR Applied Pharma Research s.a. (APR) is a Swiss Pharma company dedicated to providing patients suffering from rare diseases with innovative treatments that make a real difference in their life. Our focus as a Swiss global health care company is the identification, research, development, manufacturing, registration and commercialization of innovative, proprietary, science driven products designed to address patients' needs in niche and rare therapeutic areas on a global basis.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Switzerland
Address
Address
Via Corti 5 Balerna, (TI) 6828, CH
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/apr-applied-pharma-research-a-subsidiary-of-relief-therapeutics-is-a-finalist-in-the-2022-rare-disease-international-film-festival-301683678.html

PRNEWSWIRE
21 Nov 2022

https://www.accesswire.com/693092/Relief-Therapeutics-Wholly-Owned-Subsidiary-APR-Applied-Pharma-Research-Signs-an-Agreement-To-Acquire-Rights-to-Commercialize-a-Novel-Dosage-Form-for-the-Treatment-of-PKU

ACCESSWIRE
15 Mar 2022

https://finance.yahoo.com/news/relief-therapeutics-wholly-owned-subsidiary-052000724.html

YAHOO
27 Oct 2021

https://www.biospace.com/article/releases/relief-therapeutics-reports-two-publications-of-positive-data-on-nexodyn-r-aos-for-hard-to-heal-ulcers/?s=71

BIOSPACE
20 Oct 2021

https://www.biospace.com/article/releases/relief-therapeutics-wholly-owned-subsidiary-apr-applied-pharma-research-launches-pku-golike-r-krunch-in-germany-and-italy/?s=71

BIOSPACE
09 Sep 2021

https://www.pharmiweb.com/press-release/2021-06-29/relief-and-apr-applied-pharma-research-sign-and-close-definitive-agreement-for-relief-to-acquire-all

PHARMIWEB
29 Jun 2021

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty